Current treatments for non-small cell lung cancer
Despite improved methods of diagnosis and the development of different treatments, mortality from lung cancer remains surprisingly high. Non-small cell lung cancer (NSCLC) accounts for the large majority of lung cancer cases. Therefore, it is important to review current methods of diagnosis and trea...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.945102/full |
| _version_ | 1828423021063307264 |
|---|---|
| author | Qianqian Guo Liwei Liu Zelong Chen Yannan Fan Yang Zhou Ziqiao Yuan Wenzhou Zhang |
| author_facet | Qianqian Guo Liwei Liu Zelong Chen Yannan Fan Yang Zhou Ziqiao Yuan Wenzhou Zhang |
| author_sort | Qianqian Guo |
| collection | DOAJ |
| description | Despite improved methods of diagnosis and the development of different treatments, mortality from lung cancer remains surprisingly high. Non-small cell lung cancer (NSCLC) accounts for the large majority of lung cancer cases. Therefore, it is important to review current methods of diagnosis and treatments of NSCLC in the clinic and preclinic. In this review, we describe, as a guide for clinicians, current diagnostic methods and therapies (such as chemotherapy, chemoradiotherapy, targeted therapy, antiangiogenic therapy, immunotherapy, and combination therapy) for NSCLC. |
| first_indexed | 2024-12-10T15:56:25Z |
| format | Article |
| id | doaj.art-81f09d0c75244bc992c85e542df78c91 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-10T15:56:25Z |
| publishDate | 2022-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-81f09d0c75244bc992c85e542df78c912022-12-22T01:42:38ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-08-011210.3389/fonc.2022.945102945102Current treatments for non-small cell lung cancerQianqian Guo0Liwei Liu1Zelong Chen2Yannan Fan3Yang Zhou4Ziqiao Yuan5Wenzhou Zhang6Department of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou, ChinaDepartment of Pharmacy, First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaAffiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Artificial Intelligence and IoT Smart Medical Engineering Research Center of Henan Province, Zhengzhou, ChinaDepartment of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou, ChinaChildren’s Hospital Affiliated to Zhengzhou University, Henan Children’s Hospital, Zhengzhou Children’s Hospital, Zhengzhou, ChinaKey Laboratory of Advanced Drug Preparation Technologies, Ministry of Education, School of Pharmaceutical Sciences, Zhengzhou University, State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, ChinaDepartment of Pharmacy, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou University, Zhengzhou, ChinaDespite improved methods of diagnosis and the development of different treatments, mortality from lung cancer remains surprisingly high. Non-small cell lung cancer (NSCLC) accounts for the large majority of lung cancer cases. Therefore, it is important to review current methods of diagnosis and treatments of NSCLC in the clinic and preclinic. In this review, we describe, as a guide for clinicians, current diagnostic methods and therapies (such as chemotherapy, chemoradiotherapy, targeted therapy, antiangiogenic therapy, immunotherapy, and combination therapy) for NSCLC.https://www.frontiersin.org/articles/10.3389/fonc.2022.945102/fullNSCLCdiagnosischemotherapychemoradiotherapytargeted therapyantiangiogenic therapy |
| spellingShingle | Qianqian Guo Liwei Liu Zelong Chen Yannan Fan Yang Zhou Ziqiao Yuan Wenzhou Zhang Current treatments for non-small cell lung cancer Frontiers in Oncology NSCLC diagnosis chemotherapy chemoradiotherapy targeted therapy antiangiogenic therapy |
| title | Current treatments for non-small cell lung cancer |
| title_full | Current treatments for non-small cell lung cancer |
| title_fullStr | Current treatments for non-small cell lung cancer |
| title_full_unstemmed | Current treatments for non-small cell lung cancer |
| title_short | Current treatments for non-small cell lung cancer |
| title_sort | current treatments for non small cell lung cancer |
| topic | NSCLC diagnosis chemotherapy chemoradiotherapy targeted therapy antiangiogenic therapy |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2022.945102/full |
| work_keys_str_mv | AT qianqianguo currenttreatmentsfornonsmallcelllungcancer AT liweiliu currenttreatmentsfornonsmallcelllungcancer AT zelongchen currenttreatmentsfornonsmallcelllungcancer AT yannanfan currenttreatmentsfornonsmallcelllungcancer AT yangzhou currenttreatmentsfornonsmallcelllungcancer AT ziqiaoyuan currenttreatmentsfornonsmallcelllungcancer AT wenzhouzhang currenttreatmentsfornonsmallcelllungcancer |